See more : CNBX Pharmaceuticals Inc. (CNBX) Income Statement Analysis – Financial Results
Complete financial analysis of Mohammed Hasan AlNaqool Sons Co. (9514.SR) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Mohammed Hasan AlNaqool Sons Co., a leading company in the Construction Materials industry within the Basic Materials sector.
You may be interested
- Natraj Proteins Limited (NATRAJPR.BO) Income Statement Analysis – Financial Results
- MINEBEA MITSUMI Inc. (MNBEF) Income Statement Analysis – Financial Results
- Simply Better Brands Corp. (SBBC.V) Income Statement Analysis – Financial Results
- Zhejiang Shibao Company Limited (002703.SZ) Income Statement Analysis – Financial Results
- CJ Corporation (00104K.KS) Income Statement Analysis – Financial Results
Mohammed Hasan AlNaqool Sons Co. (9514.SR)
About Mohammed Hasan AlNaqool Sons Co.
Manufacturing and production of ready-mixed concrete
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|
| Revenue | 43.29M | 43.23M | 53.32M | 44.83M | 34.35M | 4.90M | 5.70M |
| Cost of Revenue | 37.50M | 38.54M | 41.84M | 34.63M | 26.47M | 23.81M | 19.96M |
| Gross Profit | 5.79M | 4.69M | 11.48M | 10.21M | 7.88M | -18.91M | -14.26M |
| Gross Profit Ratio | 13.37% | 10.84% | 21.54% | 22.77% | 22.95% | -385.85% | -249.91% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 913.56K | 1.96M | 1.26M | 1.41M | 769.86K | 459.89K | 379.70K |
| Selling & Marketing | 2.57M | 1.65M | 1.54M | 0.00 | 0.00 | 606.66K | 2.73M |
| SG&A | 3.48M | 3.62M | 2.80M | 1.41M | 769.86K | 1.07M | 3.11M |
| Other Expenses | 245.49K | -2.52M | -1.30M | 137.20K | 581.77K | 0.00 | 128.26K |
| Operating Expenses | 3.48M | -2.52M | -1.30M | 3.63M | 1.75M | 1.07M | 128.26K |
| Cost & Expenses | 41.02M | 38.54M | 41.84M | 38.25M | 28.22M | 24.88M | 128.26K |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 1.52M | 704.28K | 453.56K | 66.84K | 279.70K | 1.24M | 3.31M |
| Depreciation & Amortization | 4.72M | 3.69M | 3.90M | 3.71M | 3.61M | 3.52M | 3.49M |
| EBITDA | 6.80M | 5.40M | 14.20M | 10.43M | 10.51M | 7.84M | 5.99M |
| EBITDA Ratio | 15.70% | 5.01% | 19.10% | 15.19% | 27.03% | 100.00% | 102.25% |
| Operating Income | 2.26M | 2.16M | 10.18M | 6.72M | 6.71M | 4.90M | 5.83M |
| Operating Income Ratio | 5.23% | 5.01% | 19.10% | 14.99% | 19.54% | 100.00% | 102.25% |
| Total Other Income/Expenses | -1.67M | 55.10K | 1.46M | -763.75K | 98.86K | -1.77M | 128.26K |
| Income Before Tax | 592.01K | 1.46M | 9.85M | 6.65M | 6.42M | 3.66M | 2.53M |
| Income Before Tax Ratio | 1.37% | 3.38% | 18.47% | 14.84% | 18.70% | 74.66% | 44.27% |
| Income Tax Expense | 884.60K | -7.74M | 645.92K | 175.29K | 168.91K | 91.49K | 69.10K |
| Net Income | -292.59K | 9.20M | 9.20M | 6.48M | 6.25M | 3.57M | 2.46M |
| Net Income Ratio | -0.68% | 21.29% | 17.26% | 14.45% | 18.21% | 72.80% | 43.06% |
| EPS | -0.10 | 3.17 | 3.17 | 2.23 | 2.16 | 1.23 | 1.07 |
| EPS Diluted | -0.10 | 3.17 | 3.17 | 2.23 | 2.16 | 1.23 | 1.07 |
| Weighted Avg Shares Out | 2.90M | 2.90M | 2.90M | 2.90M | 2.90M | 2.90M | 2.30M |
| Weighted Avg Shares Out (Dil) | 2.90M | 2.90M | 2.90M | 2.90M | 2.90M | 2.90M | 2.30M |
No news found for: 9514.SR
Source: https://incomestatements.info
Category: Stock Reports